Morgan Stanley Natera, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Natera, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,136,531 shares of NTRA stock, worth $191 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,136,531

Previous 1,435,462 20.82%

Holding current value

$191 Million

Previous $155 Million 7.07%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $29.2 Million - $38.8 Million	-298,931 Reduced 20.82%	1,136,531 $144 Million
Q2 2024 Oct 17, 2024	BUY	$85.28 - $112.6 $17.1 Million - $22.5 Million	199,968 Added 16.19%	1,435,462 $155 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $17.1 Million - $22.5 Million	199,968 Added 16.19%	1,435,462 $155 Million
Q1 2024 Oct 17, 2024	SELL	$59.21 - $92.9 $11.8 Million - $18.6 Million	-199,968 Reduced 13.93%	1,235,494 $113 Million
Q1 2024 Aug 16, 2024	SELL	$59.21 - $92.9 $3.8 Million - $5.96 Million	-64,106 Reduced 4.93%	1,235,494 $113 Million
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $3.8 Million - $5.96 Million	-64,106 Reduced 4.93%	1,235,494 $113 Million
Q4 2023 Aug 16, 2024	SELL	$37.55 - $62.64 $5.1 Million - $8.51 Million	-135,862 Reduced 9.46%	1,299,600 $81.4 Million
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $4.04 Million - $6.75 Million	107,721 Added 9.04%	1,299,600 $81.4 Million
Q3 2023 Nov 15, 2023	BUY	$43.4 - $62.52 $2.42 Million - $3.48 Million	55,700 Added 4.9%	1,191,879 $52.7 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $5.75 Million - $6.74 Million	-122,100 Reduced 9.7%	1,136,179 $55.3 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $962,668 - $1.53 Million	-26,324 Reduced 2.05%	1,258,279 $69.9 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $12.7 Million - $17.8 Million	371,234 Added 40.64%	1,284,603 $51.6 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $6.31 Million - $9.68 Million	-170,730 Reduced 15.75%	913,369 $40 Million
Q2 2022 Oct 27, 2022	BUY	$28.13 - $44.54 $11.9 Million - $18.8 Million	422,619 Added 63.89%	1,084,099 $38.4 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $11.9 Million - $18.8 Million	422,619 Added 63.89%	1,084,099 $38.4 Million
Q1 2022 Oct 27, 2022	SELL	$30.32 - $91.33 $12.8 Million - $38.6 Million	-422,619 Reduced 38.98%	661,480 $26.9 Million
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $12.8 Million - $38.6 Million	422,260 Added 176.52%	661,480 $26.9 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $3.61 Million - $4.97 Million	-41,798 Reduced 14.87%	239,220 $22.3 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $28.1 Million - $35.5 Million	281,018 New	281,018 $31.3 Million

Others Institutions Holding NTRA

# of Institutions

528

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account